カテゴリ： 世界, 医療/バイオ, Market Monitor Global

インフルエンザワクチンのグローバル市場展望 2023年-2029年：三価インフルエンザワクチン、四価インフルエンザワクチン

■ 英語タイトル：Vaccine for Influenza Market, Global Outlook and Forecast 2023-2029

調査会社Market Monitor Global社が発行したリサーチレポート（データ管理コード：MMG23DC14505）■ 発行会社/調査会社：Market Monitor Global
■ 商品コード：MMG23DC14505
■ 発行日：2023年12月
■ 調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
■ 産業分野：医薬品
■ ページ数：72
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後2-3営業日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Market Monitor Global社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[インフルエンザワクチンのグローバル市場展望 2023年-2029年：三価インフルエンザワクチン、四価インフルエンザワクチン]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

当調査レポートは次の情報を含め、世界のインフルエンザワクチン市場規模と予測を収録しています。・世界のインフルエンザワクチン市場：売上、2018年-2023年、2024年-2029年
・世界のインフルエンザワクチン市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のインフルエンザワクチン市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「三価インフルエンザワクチン」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

インフルエンザワクチンのグローバル主要企業は、Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 BCHT、 Jiangsu GDK、 KM Biologicsなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、インフルエンザワクチンのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のインフルエンザワクチン市場：タイプ別、2018年-2023年、2024年-2029年
世界のインフルエンザワクチン市場：タイプ別市場シェア、2022年
・三価インフルエンザワクチン、四価インフルエンザワクチン

世界のインフルエンザワクチン市場：用途別、2018年-2023年、2024年-2029年
世界のインフルエンザワクチン市場：用途別市場シェア、2022年
・6ヶ月～3年、> 3年

世界のインフルエンザワクチン市場：地域・国別、2018年-2023年、2024年-2029年
世界のインフルエンザワクチン市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるインフルエンザワクチンのグローバル売上、2018年-2023年
・主要企業におけるインフルエンザワクチンのグローバル売上シェア、2022年
・主要企業におけるインフルエンザワクチンのグローバル販売量、2018年-2023年
・主要企業におけるインフルエンザワクチンのグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 BCHT、 Jiangsu GDK、 KM Biologics

*************************************************************

・調査・分析レポートの概要
インフルエンザワクチン市場の定義
市場セグメント
世界のインフルエンザワクチン市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のインフルエンザワクチン市場規模
世界のインフルエンザワクチン市場規模：2022年 VS 2029年
世界のインフルエンザワクチン市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのインフルエンザワクチンの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のインフルエンザワクチン製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：三価インフルエンザワクチン、四価インフルエンザワクチン
インフルエンザワクチンのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：6ヶ月～3年、> 3年
インフルエンザワクチンの用途別グローバル売上・予測

・地域別市場分析
地域別インフルエンザワクチン市場規模 2022年と2029年
地域別インフルエンザワクチン売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Sanofi、 CSL、 GSK、 Viatris、 AstraZeneca、 Hualan Bio、 Changchun Institute of Biological、 Sinovac、 BCHT、 Jiangsu GDK、 KM Biologics
...

This research report provides a comprehensive analysis of the Vaccine for Influenza market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Vaccine for Influenza market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Vaccine for Influenza, challenges faced by the industry, and potential opportunities for market players.
The global Vaccine for Influenza market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Vaccine for Influenza market presents opportunities for various stakeholders, including 6 Months to 3 Years, > 3 Years. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Vaccine for Influenza market. Additionally, the growing consumer demand present avenues for market expansion.
The global Vaccine for Influenza market was valued at US$ 7384.9 million in 2022 and is projected to reach US$ 11280 million by 2029, at a CAGR of 5.8% during the forecast period.
Global key players of Vaccine for Influenza include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
Key Features:
The research report on the Vaccine for Influenza market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Vaccine for Influenza market.
Market Overview: The report provides a comprehensive overview of the Vaccine for Influenza market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Trivalent Influenza Vaccine, Quadrivalent Influenza Vaccine), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Vaccine for Influenza market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Vaccine for Influenza market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Vaccine for Influenza market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Vaccine for Influenza market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Vaccine for Influenza market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Vaccine for Influenza market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Vaccine for Influenza, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Vaccine for Influenza market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Vaccine for Influenza market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Market segment by Application
6 Months to 3 Years
> 3 Years
Global Vaccine for Influenza Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Vaccine for Influenza, market overview.
Chapter 2: Global Vaccine for Influenza market size in revenue and volume.
Chapter 3: Detailed analysis of Vaccine for Influenza manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Vaccine for Influenza in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Vaccine for Influenza capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

*** レポート目次（コンテンツ）***

1 Introduction to Research & Analysis Reports
1.1 Vaccine for Influenza Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Vaccine for Influenza Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Vaccine for Influenza Overall Market Size
2.1 Global Vaccine for Influenza Market Size: 2022 VS 2029
2.2 Global Vaccine for Influenza Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Vaccine for Influenza Sales: 2018-2029
3 Company Landscape
3.1 Top Vaccine for Influenza Players in Global Market
3.2 Top Global Vaccine for Influenza Companies Ranked by Revenue
3.3 Global Vaccine for Influenza Revenue by Companies
3.4 Global Vaccine for Influenza Sales by Companies
3.5 Global Vaccine for Influenza Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Vaccine for Influenza Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Vaccine for Influenza Product Type
3.8 Tier 1, Tier 2 and Tier 3 Vaccine for Influenza Players in Global Market
3.8.1 List of Global Tier 1 Vaccine for Influenza Companies
3.8.2 List of Global Tier 2 and Tier 3 Vaccine for Influenza Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Vaccine for Influenza Market Size Markets, 2022 & 2029
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type – Global Vaccine for Influenza Revenue & Forecasts
4.2.1 By Type – Global Vaccine for Influenza Revenue, 2018-2023
4.2.2 By Type – Global Vaccine for Influenza Revenue, 2024-2029
4.2.3 By Type – Global Vaccine for Influenza Revenue Market Share, 2018-2029
4.3 By Type – Global Vaccine for Influenza Sales & Forecasts
4.3.1 By Type – Global Vaccine for Influenza Sales, 2018-2023
4.3.2 By Type – Global Vaccine for Influenza Sales, 2024-2029
4.3.3 By Type – Global Vaccine for Influenza Sales Market Share, 2018-2029
4.4 By Type – Global Vaccine for Influenza Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Vaccine for Influenza Market Size, 2022 & 2029
5.1.2 6 Months to 3 Years
5.1.3 > 3 Years
5.2 By Application – Global Vaccine for Influenza Revenue & Forecasts
5.2.1 By Application – Global Vaccine for Influenza Revenue, 2018-2023
5.2.2 By Application – Global Vaccine for Influenza Revenue, 2024-2029
5.2.3 By Application – Global Vaccine for Influenza Revenue Market Share, 2018-2029
5.3 By Application – Global Vaccine for Influenza Sales & Forecasts
5.3.1 By Application – Global Vaccine for Influenza Sales, 2018-2023
5.3.2 By Application – Global Vaccine for Influenza Sales, 2024-2029
5.3.3 By Application – Global Vaccine for Influenza Sales Market Share, 2018-2029
5.4 By Application – Global Vaccine for Influenza Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Vaccine for Influenza Market Size, 2022 & 2029
6.2 By Region – Global Vaccine for Influenza Revenue & Forecasts
6.2.1 By Region – Global Vaccine for Influenza Revenue, 2018-2023
6.2.2 By Region – Global Vaccine for Influenza Revenue, 2024-2029
6.2.3 By Region – Global Vaccine for Influenza Revenue Market Share, 2018-2029
6.3 By Region – Global Vaccine for Influenza Sales & Forecasts
6.3.1 By Region – Global Vaccine for Influenza Sales, 2018-2023
6.3.2 By Region – Global Vaccine for Influenza Sales, 2024-2029
6.3.3 By Region – Global Vaccine for Influenza Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Vaccine for Influenza Revenue, 2018-2029
6.4.2 By Country – North America Vaccine for Influenza Sales, 2018-2029
6.4.3 US Vaccine for Influenza Market Size, 2018-2029
6.4.4 Canada Vaccine for Influenza Market Size, 2018-2029
6.4.5 Mexico Vaccine for Influenza Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Vaccine for Influenza Revenue, 2018-2029
6.5.2 By Country – Europe Vaccine for Influenza Sales, 2018-2029
6.5.3 Germany Vaccine for Influenza Market Size, 2018-2029
6.5.4 France Vaccine for Influenza Market Size, 2018-2029
6.5.5 U.K. Vaccine for Influenza Market Size, 2018-2029
6.5.6 Italy Vaccine for Influenza Market Size, 2018-2029
6.5.7 Russia Vaccine for Influenza Market Size, 2018-2029
6.5.8 Nordic Countries Vaccine for Influenza Market Size, 2018-2029
6.5.9 Benelux Vaccine for Influenza Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Vaccine for Influenza Revenue, 2018-2029
6.6.2 By Region – Asia Vaccine for Influenza Sales, 2018-2029
6.6.3 China Vaccine for Influenza Market Size, 2018-2029
6.6.4 Japan Vaccine for Influenza Market Size, 2018-2029
6.6.5 South Korea Vaccine for Influenza Market Size, 2018-2029
6.6.6 Southeast Asia Vaccine for Influenza Market Size, 2018-2029
6.6.7 India Vaccine for Influenza Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Vaccine for Influenza Revenue, 2018-2029
6.7.2 By Country – South America Vaccine for Influenza Sales, 2018-2029
6.7.3 Brazil Vaccine for Influenza Market Size, 2018-2029
6.7.4 Argentina Vaccine for Influenza Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Vaccine for Influenza Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Vaccine for Influenza Sales, 2018-2029
6.8.3 Turkey Vaccine for Influenza Market Size, 2018-2029
6.8.4 Israel Vaccine for Influenza Market Size, 2018-2029
6.8.5 Saudi Arabia Vaccine for Influenza Market Size, 2018-2029
6.8.6 UAE Vaccine for Influenza Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Vaccine for Influenza Major Product Offerings
7.1.4 Sanofi Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 CSL
7.2.1 CSL Company Summary
7.2.2 CSL Business Overview
7.2.3 CSL Vaccine for Influenza Major Product Offerings
7.2.4 CSL Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.2.5 CSL Key News & Latest Developments
7.3 GSK
7.3.1 GSK Company Summary
7.3.2 GSK Business Overview
7.3.3 GSK Vaccine for Influenza Major Product Offerings
7.3.4 GSK Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.3.5 GSK Key News & Latest Developments
7.4 Viatris
7.4.1 Viatris Company Summary
7.4.2 Viatris Business Overview
7.4.3 Viatris Vaccine for Influenza Major Product Offerings
7.4.4 Viatris Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.4.5 Viatris Key News & Latest Developments
7.5 AstraZeneca
7.5.1 AstraZeneca Company Summary
7.5.2 AstraZeneca Business Overview
7.5.3 AstraZeneca Vaccine for Influenza Major Product Offerings
7.5.4 AstraZeneca Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.5.5 AstraZeneca Key News & Latest Developments
7.6 Hualan Bio
7.6.1 Hualan Bio Company Summary
7.6.2 Hualan Bio Business Overview
7.6.3 Hualan Bio Vaccine for Influenza Major Product Offerings
7.6.4 Hualan Bio Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.6.5 Hualan Bio Key News & Latest Developments
7.7 Changchun Institute of Biological
7.7.1 Changchun Institute of Biological Company Summary
7.7.2 Changchun Institute of Biological Business Overview
7.7.3 Changchun Institute of Biological Vaccine for Influenza Major Product Offerings
7.7.4 Changchun Institute of Biological Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.7.5 Changchun Institute of Biological Key News & Latest Developments
7.8 Sinovac
7.8.1 Sinovac Company Summary
7.8.2 Sinovac Business Overview
7.8.3 Sinovac Vaccine for Influenza Major Product Offerings
7.8.4 Sinovac Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.8.5 Sinovac Key News & Latest Developments
7.9 BCHT
7.9.1 BCHT Company Summary
7.9.2 BCHT Business Overview
7.9.3 BCHT Vaccine for Influenza Major Product Offerings
7.9.4 BCHT Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.9.5 BCHT Key News & Latest Developments
7.10 Jiangsu GDK
7.10.1 Jiangsu GDK Company Summary
7.10.2 Jiangsu GDK Business Overview
7.10.3 Jiangsu GDK Vaccine for Influenza Major Product Offerings
7.10.4 Jiangsu GDK Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.10.5 Jiangsu GDK Key News & Latest Developments
7.11 KM Biologics
7.11.1 KM Biologics Company Summary
7.11.2 KM Biologics Business Overview
7.11.3 KM Biologics Vaccine for Influenza Major Product Offerings
7.11.4 KM Biologics Vaccine for Influenza Sales and Revenue in Global (2018-2023)
7.11.5 KM Biologics Key News & Latest Developments
8 Global Vaccine for Influenza Production Capacity, Analysis
8.1 Global Vaccine for Influenza Production Capacity, 2018-2029
8.2 Vaccine for Influenza Production Capacity of Key Manufacturers in Global Market
8.3 Global Vaccine for Influenza Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Vaccine for Influenza Supply Chain Analysis
10.1 Vaccine for Influenza Industry Value Chain
10.2 Vaccine for Influenza Upstream Market
10.3 Vaccine for Influenza Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Vaccine for Influenza Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Vaccine for Influenza in Global Market
Table 2. Top Vaccine for Influenza Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Vaccine for Influenza Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Vaccine for Influenza Revenue Share by Companies, 2018-2023
Table 5. Global Vaccine for Influenza Sales by Companies, (M Units), 2018-2023
Table 6. Global Vaccine for Influenza Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Vaccine for Influenza Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Vaccine for Influenza Product Type
Table 9. List of Global Tier 1 Vaccine for Influenza Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Vaccine for Influenza Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Vaccine for Influenza Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Vaccine for Influenza Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Vaccine for Influenza Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Vaccine for Influenza Sales (M Units), 2018-2023
Table 15. By Type - Global Vaccine for Influenza Sales (M Units), 2024-2029
Table 16. By Application – Global Vaccine for Influenza Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Vaccine for Influenza Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Vaccine for Influenza Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Vaccine for Influenza Sales (M Units), 2018-2023
Table 20. By Application - Global Vaccine for Influenza Sales (M Units), 2024-2029
Table 21. By Region – Global Vaccine for Influenza Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Vaccine for Influenza Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Vaccine for Influenza Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Vaccine for Influenza Sales (M Units), 2018-2023
Table 25. By Region - Global Vaccine for Influenza Sales (M Units), 2024-2029
Table 26. By Country - North America Vaccine for Influenza Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Vaccine for Influenza Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Vaccine for Influenza Sales, (M Units), 2018-2023
Table 29. By Country - North America Vaccine for Influenza Sales, (M Units), 2024-2029
Table 30. By Country - Europe Vaccine for Influenza Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Vaccine for Influenza Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Vaccine for Influenza Sales, (M Units), 2018-2023
Table 33. By Country - Europe Vaccine for Influenza Sales, (M Units), 2024-2029
Table 34. By Region - Asia Vaccine for Influenza Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Vaccine for Influenza Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Vaccine for Influenza Sales, (M Units), 2018-2023
Table 37. By Region - Asia Vaccine for Influenza Sales, (M Units), 2024-2029
Table 38. By Country - South America Vaccine for Influenza Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Vaccine for Influenza Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Vaccine for Influenza Sales, (M Units), 2018-2023
Table 41. By Country - South America Vaccine for Influenza Sales, (M Units), 2024-2029
Table 42. By Country - Middle East & Africa Vaccine for Influenza Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Vaccine for Influenza Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Vaccine for Influenza Sales, (M Units), 2018-2023
Table 45. By Country - Middle East & Africa Vaccine for Influenza Sales, (M Units), 2024-2029
Table 46. Sanofi Company Summary
Table 47. Sanofi Vaccine for Influenza Product Offerings
Table 48. Sanofi Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sanofi Key News & Latest Developments
Table 50. CSL Company Summary
Table 51. CSL Vaccine for Influenza Product Offerings
Table 52. CSL Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. CSL Key News & Latest Developments
Table 54. GSK Company Summary
Table 55. GSK Vaccine for Influenza Product Offerings
Table 56. GSK Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. GSK Key News & Latest Developments
Table 58. Viatris Company Summary
Table 59. Viatris Vaccine for Influenza Product Offerings
Table 60. Viatris Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Viatris Key News & Latest Developments
Table 62. AstraZeneca Company Summary
Table 63. AstraZeneca Vaccine for Influenza Product Offerings
Table 64. AstraZeneca Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. AstraZeneca Key News & Latest Developments
Table 66. Hualan Bio Company Summary
Table 67. Hualan Bio Vaccine for Influenza Product Offerings
Table 68. Hualan Bio Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Hualan Bio Key News & Latest Developments
Table 70. Changchun Institute of Biological Company Summary
Table 71. Changchun Institute of Biological Vaccine for Influenza Product Offerings
Table 72. Changchun Institute of Biological Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Changchun Institute of Biological Key News & Latest Developments
Table 74. Sinovac Company Summary
Table 75. Sinovac Vaccine for Influenza Product Offerings
Table 76. Sinovac Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Sinovac Key News & Latest Developments
Table 78. BCHT Company Summary
Table 79. BCHT Vaccine for Influenza Product Offerings
Table 80. BCHT Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. BCHT Key News & Latest Developments
Table 82. Jiangsu GDK Company Summary
Table 83. Jiangsu GDK Vaccine for Influenza Product Offerings
Table 84. Jiangsu GDK Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. Jiangsu GDK Key News & Latest Developments
Table 86. KM Biologics Company Summary
Table 87. KM Biologics Vaccine for Influenza Product Offerings
Table 88. KM Biologics Vaccine for Influenza Sales (M Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. KM Biologics Key News & Latest Developments
Table 90. Vaccine for Influenza Production Capacity (M Units) of Key Manufacturers in Global Market, 2021-2023 (M Units)
Table 91. Global Vaccine for Influenza Capacity Market Share of Key Manufacturers, 2021-2023
Table 92. Global Vaccine for Influenza Production by Region, 2018-2023 (M Units)
Table 93. Global Vaccine for Influenza Production by Region, 2024-2029 (M Units)
Table 94. Vaccine for Influenza Market Opportunities & Trends in Global Market
Table 95. Vaccine for Influenza Market Drivers in Global Market
Table 96. Vaccine for Influenza Market Restraints in Global Market
Table 97. Vaccine for Influenza Raw Materials
Table 98. Vaccine for Influenza Raw Materials Suppliers in Global Market
Table 99. Typical Vaccine for Influenza Downstream
Table 100. Vaccine for Influenza Downstream Clients in Global Market
Table 101. Vaccine for Influenza Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Vaccine for Influenza Segment by Type in 2022
Figure 2. Vaccine for Influenza Segment by Application in 2022
Figure 3. Global Vaccine for Influenza Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Vaccine for Influenza Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Vaccine for Influenza Revenue, 2018-2029 (US$, Mn)
Figure 7. Vaccine for Influenza Sales in Global Market: 2018-2029 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Vaccine for Influenza Revenue in 2022
Figure 9. By Type - Global Vaccine for Influenza Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Vaccine for Influenza Revenue Market Share, 2018-2029
Figure 11. By Type - Global Vaccine for Influenza Sales Market Share, 2018-2029
Figure 12. By Type - Global Vaccine for Influenza Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Vaccine for Influenza Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Vaccine for Influenza Revenue Market Share, 2018-2029
Figure 15. By Application - Global Vaccine for Influenza Sales Market Share, 2018-2029
Figure 16. By Application - Global Vaccine for Influenza Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Vaccine for Influenza Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Vaccine for Influenza Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Vaccine for Influenza Revenue Market Share, 2018-2029
Figure 20. By Region - Global Vaccine for Influenza Sales Market Share, 2018-2029
Figure 21. By Country - North America Vaccine for Influenza Revenue Market Share, 2018-2029
Figure 22. By Country - North America Vaccine for Influenza Sales Market Share, 2018-2029
Figure 23. US Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Vaccine for Influenza Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Vaccine for Influenza Sales Market Share, 2018-2029
Figure 28. Germany Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 29. France Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Vaccine for Influenza Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Vaccine for Influenza Sales Market Share, 2018-2029
Figure 37. China Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 41. India Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Vaccine for Influenza Revenue Market Share, 2018-2029
Figure 43. By Country - South America Vaccine for Influenza Sales Market Share, 2018-2029
Figure 44. Brazil Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Vaccine for Influenza Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Vaccine for Influenza Sales Market Share, 2018-2029
Figure 48. Turkey Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Vaccine for Influenza Revenue, (US$, Mn), 2018-2029
Figure 52. Global Vaccine for Influenza Production Capacity (M Units), 2018-2029
Figure 53. The Percentage of Production Vaccine for Influenza by Region, 2022 VS 2029
Figure 54. Vaccine for Influenza Industry Value Chain
Figure 55. Marketing Channels


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • インフルエンザワクチンのグローバル市場展望 2023年-2029年：3価インフルエンザワクチン、4価インフルエンザワクチン
  • インフルエンザワクチンのグローバル市場展望 2023年-2029年：3価インフルエンザワクチン、4価インフルエンザワクチン
  • アジュバント使用インフルエンザワクチンのグローバル市場展望 2023年-2029年：バイアル、充填済み
  • 小児用インフルエンザワクチンのグローバル市場展望 2023年-2029年：点鼻薬、注射
  • 弱毒生インフルエンザワクチン（LAIV）のグローバル市場展望 2023年-2029年：3価インフルエンザワクチン、4価インフルエンザワクチン
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(MMG23DC14505 )"インフルエンザワクチンのグローバル市場展望 2023年-2029年：三価インフルエンザワクチン、四価インフルエンザワクチン" (英文：Vaccine for Influenza Market, Global Outlook and Forecast 2023-2029)はMarket Monitor Global社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。